New York, NY -- (SBWIRE) -- 12/23/2013 -- CaddyStocks.com is keen to discover penny stocks with the potential to make short and long-term gains. We’ve been improving our skills as traders and analysts for years, and we know – from experience – which indicators to look for. That’s why we’ve been able to choice some of the market’s biggest winners and send them to our followers before the rest of the market has any idea of what hit them. Here are some hot stocks to watch for:- C Rexahn Pharmaceuticals, Inc.(NYSEMKT:RNN), Novacopper Inc(NYSEMKT:NCQ), Alimera Sciences Inc(NASDAQ:ALIM), Regulus Therapeutics Inc(NASDAQ:RGLS)
Rexahn Pharmaceuticals, Inc.(NYSEMKT:RNN) plunged -2.55% and closed at $0.429 on a traded volume of 1.06M shares, in comparison to 1.29M shares of average trading volume. The company has a total market capitalization of $62.91 million.
Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide.
Has RNN Found The Bottom and Ready To Move Up? Find Out Here
Novacopper Inc(NYSEMKT:NCQ) surged 2.86% and closed at $1.44 on a traded volume of 1.05M shares, whereas its average trading volume is 311450 shares. The Intra-day range for the stock is $1.38 and $1.50.
NovaCopper Inc. (NovaCopper) is a base metals exploration company. The Company is focused on exploring and developing the Ambler mining district, which VMS deposits containing copper, zinc, lead, gold and silver and carbonate replacement deposits containing copper, cobalt and silver.
For How Long NCQ Gloss will Attract Investors? Find out via this report
Alimera Sciences Inc(NASDAQ:ALIM) surged 0.48% and closed at $4.17. The 52-week ange for the stock is $1.55 and $5.69 and during the previous trading session the stock touched its highest price at $4.43.Its introductory price for the day was $3.75, with the overall traded volume of 1.05M shares.
Alimera Sciences, Inc.is a biopharmaceutical company that develops and commercializes prescription ophthalmic pharmaceuticals. The Company advanced product candidate, ILUVIEN, is a tiny, cylindrical polyimide tube that contains 190 g of fluocinolone acetonide (FAc), a corticosteroid with a history of treating ocular diseases.
Will ALIM Continue To Move Higher? Find Out Here
Regulus Therapeutics Inc(NASDAQ:RGLS) surged 3.96% and closed at $6.82. The 52-week ange for the stock is $4.67 and $12.89 and during the previous trading session the stock touched its highest price at $6.90.Its introductory price for the day was $6.52, with the overall traded volume of 1.05M shares.
Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing microRNAs to treat a range of diseases. microRNAs are naturally occurring ribonucleic acid (RNA), molecules that play a critical role in regulating key biological pathways.
Will RGLS Continue To Move Higher? Find Out Here
CaddyStocks record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
The employees of CaddyStocks.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
The information contained in the website and in any reports is provided on an “as-is” basis and has not been verified by us. All information on profiled companies is provided by such companies, or is available from public sources and no representation; warranty or guaranty is made as to its accuracy or completeness. CaddyStocks.com is under no obligation to update any information or opinions contained herein. Investors should not rely solely on the information presented herein, but rather use such information as a starting point for doing additional independent research on the profiled companies in order to form investment strategies and decisions. Neither CaddyStocks.com nor any of its owners, operators, or affiliates shall be liable to any subscriber or reader for any losses or damages arising from the use of any information contained herein, caused in whole or part by CaddyStocks.com in procuring, compiling, interpreting, reporting, or delivering any of the information contained herein or otherwise delivered.
Read Full Disclaimer at: http://caddystocks.com/disclaimer.html/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)